Compositions And Methods For Treating Disorders Ameliorated By Muscarnic Receptor Activation

Patent No. EP3856182 (titled "Compositions And Methods For Treating Disorders Ameliorated By Muscarnic Receptor Activation") was filed by Karuna Therapeutics on Sep 27, 2019. The application was issued on Dec 24, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJul 30, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3856182

KARUNA THERAPEUTICS
Application Number
EP19865548A
Filing Date
Sep 27, 2019
Status
Granted And Under Opposition
Nov 21, 2025
Publication Date
Dec 24, 2025